Dexrazoxane

The CARDIOPROTECT Trial

Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Dexrazoxane to Protect Against Hemorrhagic STEMI

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia

Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma

Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma

CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients

Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma

Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery

OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients

Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients